Bloomage BioTechnology (688363) Stock Overview
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
688363 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Bloomage BioTechnology Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥37.36 |
| 52 Week High | CN¥61.85 |
| 52 Week Low | CN¥32.92 |
| Beta | 0.51 |
| 1 Month Change | 3.20% |
| 3 Month Change | -13.52% |
| 1 Year Change | -27.50% |
| 3 Year Change | -58.57% |
| 5 Year Change | -87.53% |
| Change since IPO | -56.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688363 | CN Personal Products | CN Market | |
|---|---|---|---|
| 7D | 6.9% | 3.3% | -1.5% |
| 1Y | -27.5% | -25.4% | 19.0% |
Return vs Industry: 688363 underperformed the CN Personal Products industry which returned -25.4% over the past year.
Return vs Market: 688363 underperformed the CN Market which returned 19% over the past year.
Price Volatility
| 688363 volatility | |
|---|---|
| 688363 Average Weekly Movement | 5.6% |
| Personal Products Industry Average Movement | 5.5% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in CN Market | 11.6% |
| 10% least volatile stocks in CN Market | 4.3% |
Stable Share Price: 688363 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688363's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 3,698 | Yan Zhao | www.bloomagebioactive.com |
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers beauty and care products under brand Hymagic-VCHA VC Hylauronic Acid; Biomeet-MarineDNA; Bioyouth-SPG Schizophyllan Gel; Hymagic-GluHA; Bloomsurfact EncapCare RP; Bloomsurfact Sodium Surfactin; Hybloom Minitrue; Bioyouth-EGT Pure Ultrapure Ergothioneine; miniHA HA-Oligo degraded by hyaluronidase; microHA Super Active Hyaluronic Acid; Hymagic-AcHA Sodium Acetylated Hyaluronate; Hymagic-4D 4D Hyaluronic Acid; Hybloom Zinc Hyaluronate; Hybloom Sodium Hyaluronate 1% Solution; Hybloom Sodium Hyaluronate; Hybloom Oligo Hyaluronic Acid; Hybloom Low Molecular Weight Sodium Hyaluronate; Hybloom Hydrolyzed Hyaluronic Acid; Hybloom High Molecular Weight Sodium Hyaluronate; Hyanutra-RH Hair Nourishing Shield; Hyafacto-PGA Super High Molecular Weight Sodium Polyglutamate; Hyafactor-PGA Sodium Polyglutamate; Hyafactor-NAG Acetyl Glucosamine; Hyacross TG100 Hyaluronic Acid Elastomer; Hyacolor Oil-dispersed Sodium Hyaluronate; Gabacare BL98T Aminobutyric Acid; cationHA-G and clear Substantive Sodium Hyaluronate; Bioyouth-Natto Natto Extract; Bioyouth-NANA N-Acetylneuraminic Acid; Bioyouth HT Silky Hyaluronic Acid; Bioyouth-EGT Pro Super Active Ergothione; Bioyouth-Brice Brown Rice Ferment Filtrate; Bioyouth-FCM Cordyceps Militaris Ferment Filtrate; Bioyouth-EGT Ergothioneine Complex; Bioyouth BLC Bluelight Care; Bioecto Ectoine; Biobloom Microecobeauty. It also provides pharma and aesthetics; nutrition and health products under the brand Hyatrue; Bloomecto; Bloomcolla; BloomseaN; BloomStem; MitoEGT L-Ergothioneine; UltraHA J Sodium Hyaluronate; MitoPQQ Pyrroloquinoline Quinone Disodium; UltraHA-CWS Sodium Hyaluronate; HAPLEX Plus Sodium Hyaluronate; Gabarelax Gamma Aminobutyric Acid; UltraHA-GI-001 Special sodium hyaluronate for gut health; and Biovivid Collagen Peptide name.
Bloomage BioTechnology Corporation Limited Fundamentals Summary
| 688363 fundamental statistics | |
|---|---|
| Market cap | CN¥17.87b |
| Earnings (TTM) | CN¥254.82m |
| Revenue (TTM) | CN¥3.95b |
Is 688363 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688363 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.95b |
| Cost of Revenue | CN¥1.32b |
| Gross Profit | CN¥2.63b |
| Other Expenses | CN¥2.38b |
| Earnings | CN¥254.82m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Aug 28, 2026
| Earnings per share (EPS) | 0.53 |
| Gross Margin | 66.62% |
| Net Profit Margin | 6.45% |
| Debt/Equity Ratio | 4.6% |
How did 688363 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/16 17:36 |
| End of Day Share Price | 2026/07/16 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bloomage BioTechnology Corporation Limited is covered by 17 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Zhuonan Xu | China International Capital Corporation Limited |
| Li Liu | China Merchants Securities (HK) Co., Ltd |